Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 20/20 | 0.68 |
| ▸ | NTRK1 | P04629 | 3/20 | 0.54 |
| ▸ | KIT | P10721 | 3/20 | 0.54 |
| ▸ | SRC | P12931 | 3/20 | 0.54 |
| ▸ | FLT3 | P36888 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3293463 | 0.93 | CSF1R (0.78) | CSF1RNTRK1KITSRCFLT3 | |
| SCHEMBL3298520 | 0.92 | CSF1R (0.70) | CSF1RNTRK1KITSRCFLT3 | |
| SCHEMBL3293608 | 0.90 | CSF1R (0.84) | CSF1RNTRK1KITSRCFLT3 | |
| SCHEMBL3291256 | 0.90 | CSF1R (0.68) | CSF1RNTRK1KITSRCFLT3 | |
| SCHEMBL4793907 | 0.87 | CSF1R (0.87) | CSF1RNTRK1KITSRCFLT3 | |
| SCHEMBL4792841 | 0.85 | CSF1R (0.47) | CSF1R | |
| SCHEMBL4892721 | 0.84 | CSF1R (0.68) | CSF1RNTRK1KITSRCFLT3 | |
| SCHEMBL4773077 | 0.83 | CSF1R (0.64) | CSF1RNTRK1KITSRCFLT3 | |
| SCHEMBL3290866 | 0.81 | CSF1R (0.78) | CSF1RNTRK1KITSRCFLT3 | |
| SCHEMBL4765053 | 0.81 | CSF1R (0.78) | CSF1RNTRK1KITSRCFLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1945637-A1 | 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-07-23 | — | — | EP | disclosed |
| WO-2007033137-A1 | 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE | JANSSEN PHARMACEUTICA, N.V. (BE) | 2007-03-22 | — | — | WO | disclosed |